GlaxoSmithKline (Belgium)
In research, GlaxoSmithKline (Belgium) stands highest in Medicine (#3,608 of 10,443 worldwide) and Health Sciences (#4,917 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Epidemiology and Immunology and Microbiology — Epidemiology is 23.7× its share of world research.
- World rank, 2022–2025
- #6,743 of 28,054 · #5,517 all time
- Rank in Belgium
- #36 of 138
- Research works
- 922 ▼ 3% vs 2013–17
- Citations
- 35k 38.1 per fractional work
- Top-10% rate
- 22.7% record average 16.5%
- Open access
- 66% world 28%
What is GlaxoSmithKline (Belgium) known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #3,608 of 10,443 | 25.5% | 106 | #3255 | |
| Health SciencesDomain | #4,917 of 11,982 | 25.0% | 110 | #4455 |
Each strip is that field’s whole ranked pool, with the notch where GlaxoSmithKline (Belgium) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does GlaxoSmithKline (Belgium) specialise in?
Where its research is concentrated relative to its size: Epidemiology takes 23.7× the share of its output that it takes of world research.
- EpidemiologySubfield · 58.1 works24×
- Immunology and MicrobiologyField · 24.5 works14×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 14.1×. Every wedge is a field page.
- Immunology and Microbiology 14.1×
- Pharmacology, Toxicology and Pharmaceutics 4.5×
- Medicine 3.2×
- Biochemistry, Genetics and Molecular Biology 1.1×
- Mathematics 1.1×
- Veterinary 1.0×
- Health Professions 0.8×
- Economics, Econometrics and Finance 0.7×
- Social Sciences 0.5×
- Decision Sciences 0.5×
- Neuroscience 0.3×
- Chemical Engineering 0.3×
- Agricultural and Biological Sciences 0.2×
- Chemistry 0.2×
- Engineering 0.1×
- Computer Science 0.1×
- Nursing 0.1×
- Dentistry 0.1×
- Business, Management and Accounting 0.1×
- Psychology 0.1×
- Energy 0.0×
- Environmental Science 0.0×
- Materials Science 0.0×
Who are the top researchers at GlaxoSmithKline (Belgium)?
Ranked on the composite score, William P. Hausdorff, Frank Struyf and Nathalie Garçon lead among researchers whose main affiliation is GlaxoSmithKline (Belgium).
- 1 William P. Hausdorff · #144,064 worldwide 201 citations · 25 works
- 2 Frank Struyf · #148,064 worldwide 204 citations · 25 works
- 3 Nathalie Garçon · #166,102 worldwide 146 citations · 24 works
- 4 Arnaud M. Didierlaurent · #262,423 worldwide 151 citations · 20 works
- 5 Johan Vekemans · #370,019 worldwide 164 citations · 15 works
- 6 Thomas C. Heineman · #487,782 worldwide 102 citations · 15 works
- 7 Thomas Breuer · #527,965 worldwide 82 citations · 19 works
- 8 Vincent Brichard · #576,295 worldwide 76 citations · 16 works
- 9 Pilar Rubio · #746,116 worldwide 3 citations · 19 works
- 10 Marta Moreira · #805,601 worldwide 7 citations · 20 works
Which keywords describe research at GlaxoSmithKline (Belgium)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Vaccine, Pathogenesis, Immune Response, Vaccine Development, Disease Burden, Human Metapneumovirus and Respiratory Syncytial Virus.
- Immune Evasion
- Hearing Loss
- ACE2 Receptor
- H1N1
- Virus
- Respiratory
- SARS-CoV-2
- Community-Acquired Pneumonia
- Vaccination
- Antimicrobial Resistance
- Neisseria meningitidis
- Vaccine Hesitancy
- COVID-19 Vaccine
- Social Media
- Pandemic
- Herpes Zoster
- Respiratory Syncytial Virus
- Disease Burden
- Immune Response
- Vaccine
- Epidemiology
- Pathogenesis
- Vaccine Development
- Human Metapneumovirus
- Immunity
- Herpesviruses
- Treatment
- Clinical Management
- Health Behavior
- Bacterial Meningitis
- Infection
- Clinical Practice Guidelines
- Respiratory Infections
- Pneumococcal Conjugate Vaccine
- Antiviral Therapy
- Antibodies
- Genomics
- Influenza
- Coronavirus
- Transplant Recipients
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology87▲ 13×45 topics
- Vaccine39▲ 56×11 topics
- Pathogenesis28▲ 32×15 topics
- Immune Response25▲ 26×13 topics
- Vaccine Development25▲ 57×7 topics
- Disease Burden18▲ 146×2 topics
- Human Metapneumovirus18▲ 229×1 topic
- Respiratory Syncytial Virus18▲ 229×1 topic
- Immunity16▲ 22×4 topics
- Herpes Zoster13▲ 262×1 topic
- Herpesviruses13▲ 262×1 topic
- Pandemic13▲ 6.9×5 topics
- Treatment13▲ 6.0×14 topics
- Social Media10▲ 4.1×3 topics
- Clinical Management10▲ 33×4 topics
- COVID-19 Vaccine10▲ 78×2 topics
- Health Behavior10▲ 55×1 topic
- Vaccine Hesitancy10▲ 84×1 topic
- Bacterial Meningitis10▲ 281×1 topic
- Neisseria meningitidis10▲ 281×1 topic
- Infection9▲ 21×4 topics
- Antimicrobial Resistance9▲ 26×5 topics
- Clinical Practice Guidelines9▲ 9.5×4 topics
- Vaccination8▲ 65×3 topics
- Respiratory Infections8▲ 41×2 topics
- Community-Acquired Pneumonia8▲ 136×1 topic
- Pneumococcal Conjugate Vaccine8▲ 136×1 topic
- SARS-CoV-28▲ 14×5 topics
- Antiviral Therapy8▲ 44×3 topics
- Respiratory7▲ 41×2 topics
- Antibodies6▲ 67×2 topics
- Virus6▲ 39×3 topics
- Genomics6▲ 12×2 topics
- H1N16▲ 119×1 topic
- Influenza6▲ 88×1 topic
- ACE2 Receptor6▲ 15×2 topics
- Coronavirus6▲ 17×3 topics
- Hearing Loss6▲ 30×2 topics
- Transplant Recipients6▲ 56×2 topics
- Immune Evasion6▲ 70×2 topics
Which research topics does GlaxoSmithKline (Belgium) publish most on?
By volume in 2022–2025: Respiratory viral infections research, Herpesvirus Infections and Treatments, Vaccine Coverage and Hesitancy and Bacterial Infections and Vaccines.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Respiratory viral infections researchEpidemiology 18 works
- 2 Herpesvirus Infections and TreatmentsEpidemiology 13 works
- 3 Vaccine Coverage and HesitancyHealth 10 works
- 4 Bacterial Infections and VaccinesMicrobiology 10 works
- 5 Pneumonia and Respiratory InfectionsEpidemiology 8 works
- 6 Influenza Virus Research StudiesEpidemiology 6 works
- 7 Cytomegalovirus and herpesvirus researchEpidemiology 5 works
- 8 SARS-CoV-2 and COVID-19 ResearchInfectious Diseases 4 works
- 9 Facial Nerve Paralysis Treatment and ResearchNeurology 4 works
- 10 Viral gastroenteritis research and epidemiologyInfectious Diseases 3 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has GlaxoSmithKline (Belgium)'s research output changed?
Output in 2018–2022 was 3% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Wavre
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.